Accelerated Approval pathway for our ST-920 gene therapy product candidate for the treatment of Fabry disease.

Presentation

Engineering of Factor IX-secreting B cells using ZF-Nuclease / AAV6 editing technology in a GMP-compatible medium

Download PDF